Skip to main content
Category

News Archive

sbir sttr seed fund logo

DoD 2017.1 SBIR & 17.A STTR Now Open For Submissions!

By News Archive

sbir-sttr-seed-fund-logo

The DoD SBIR 17.1 & STTR 17.A Broad Agency Announcements are Now Open for Proposal Submission on January 10, 2017

You may now submit your Phase I and Direct to Phase II proposals for the open SBIR 17.1 and STTR 17.A Broad Agency Announcements (BAA) through the DOD SBIR/STTR proposal submission website at https://sbir.defensebusiness.org. All proposals for this Announcement must be received by 6:00 am. ET on Wednesday, February 8, 2017.

Read More
Mediterranean-sea-pixa

Mediterranean May Hold Elixir for Age-Related Diseases | GEN

By News Archive

Mediterranean-sea-pixa

Prickly pear trees and the brown seaweed, commonly known as Peacocks tail, are a common sight in the Mediterranean. [Stephanie Ghio] It would seem that Juan Ponce de Leon’s trip to the New World in search of the fountain of youth may have been even more in vain, given that it may have been right in his “backyard.” Evidence from a new study by investigators at the University of Malta and the Centre National de la Recherche Scientifique (CNRS/University of Bordeaux) shows that chemicals in ubiquitous Mediterranean plants could hold the key to delaying age-related diseases. 

Read More
toshiba-logo

Toshiba Medical Research Institute USA, Inc. executes Lease in 1812 Ashland Avenue

By News Archive

toshiba-logo

New East Baltimore Partnership (“FC-NEBP”) and Toshiba Medical Research Institute USA, Inc. (“Toshiba Medical”) announced today that they have executed a lease to construct a medical research center at 1812 Ashland Avenue, the newest building in the Science + Technology Park at Johns Hopkins.  When it opens, the Toshiba Medical research center will showcase next-generation technology that will offer a unique opportunity at the Johns Hopkins East Baltimore Medical Campus to collaborate with researchers seeking the most advanced imaging capacity in the world.

Read More
nhlbi-nih-logo

NHLBI Funding & Research Opportunities and Announcements for January 06, 2017

By News Archive

nhlbi-nih-logo

Funding and Research Opportunities

The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:

Notices:

  • NIH & AHRQ Update Font Guidelines for Applications to Due Dates On or After 
    • January 25, 2017 
    • (NOT-OD-17-030) National Institutes of Health
  • Technical Assistance Videocast for RFA RM-16-019 “NIH Health Care Systems Research Collaboratory – Demonstration Projects for Pragmatic Clinical Trials (UG3/UH3)”
  • Notice of Availability of Frequently Asked Questions and a Recording of the Pre-application Webinar on the NIH Illuminating the Druggable Genome (IDG) Program Website for RFA-RM-16-024, RFA-RM-16-025, and RFA-RM-16-026

Requests for Applications:

  • National Centers for Cryoelectron Microscopy (U24)
    • (RFA-RM-17-002)
    • NIH Roadmap Initiatives
    • Application Receipt Date(s): June 30, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.

Program Announcements:

  • Research on the Health of Women of Underrepresented, Understudied and Underreported (U3) Populations An ORWH FY17 Administrative Supplement 
    • (Admin Supp)
    • (PA-17-101
    • Office of Research on Women’s Health
    • National Center for Advancing Translational Sciences
    • National Eye Institute
    • National Human Genome Research Institute
    • National Heart, Lung, and Blood Institute
robot-arm-technology-pixa

DARPA’s Biotech Chief Says 2017 Will “Blow Our Minds” – Scientific American

By News Archive

robot-arm-technology-pixa

The Pentagon’s research and development division, DARPA—the creative force behind the internet and GPS—retooled itself three years ago to create a new office dedicated to unraveling biology’s engineering secrets. The new Biological Technologies Office (BTO) has a mission to “harness the power of biological systems” and design new defense technology. Over the past year, with a budget of about $296 million, it has been exploring challenges including memory improvement, human–machine symbiosis and speeding up disease detection and response.

Read More
johnson-and-johnson-2-logo

Johnson & Johnson Innovation, New York State and New York Genome Center Collaborate to Launch JLABS in New York City

By News Archive

johnson-and-johnson-2-logo

Johnson & Johnson Innovation LLC, New York State and the New York Genome Center today announced a collaboration to launch a new JLABS in New York City. Called JLABS @ NYC, the 30,000-square foot facility will be located at the New York Genome Center (NYGC) in SoHo and will open in 2018. The project is receiving $17 million in New York State funding. The site will be open to biotech, pharmaceutical, medical device and consumer health companies. A QuickFire Challenge seeking companies working in these areas, particularly startups working on cross-sector solutions to prevent, intercept or cure diseases, will be launched by Johnson & Johnson Innovation, with the winner(s) eligible for one year of residency at JLABS @ NYC.

Read More
illumina-logo

Illumina & IBM Watson form cancer genomics partnership – MedCity News

By News Archive

illumina-logo

IBM Watson Health and Illumina have officially joined forces, announcing a new partnership on Monday as the J.P. Morgan Healthcare Conference kicks off.

Watson Health is a serial collaborator, but it chose a pivotal agreement to spotlight at JPM. By integrating with Illumina’s platform, the two companies can create an end-to-end tumor sequencing workflow that could increase accessibility and scalability in the field. It could also address a major problem, said Watson Health Vice President Steve Harvey; a lack of standardization.

Read More

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.